Literature DB >> 12355285

Correlates of urinary incontinence in pregnancy.

L Hvidman1, L Hvidman1, A Foldspang, S Mommsen, J Bugge Nielsen.   

Abstract

In a population sample, the period prevalence of urinary incontinence (UI) during pregnancy was found to be 19.9% and 24.1% among 352 nulliparous and 290 primiparous women, respectively. The first UI episode ever was experienced by 16.7% and 7.0% during the two last trimesters of the first and second pregnancies, respectively. None of the pregnancy-specific risk factors, such as emesis and birthweight, was significantly associated with UI during pregnancy. Previous UI was a significant risk factor for period prevalent UI during pregnancy, explaining 34% and 83% of pregnancy UI for the nulliparous and the primiparous, respectively. The present data suggest pregnancy UI not to be provoked by the mere onset of pregnancy, but by increasing hormonal concentrations or local tissue changes caused by hormones, whereas there was no support for a theory based on increasing pressure on the bladder caused by the weight of the fetus.

Entities:  

Mesh:

Year:  2002        PMID: 12355285     DOI: 10.1007/s001920200061

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  19 in total

1.  Clinical impact of and contributing factors to urinary incontinence in women 5 years after first delivery.

Authors:  Ching-Chung Liang; Ming-Ping Wu; Shu-Jen Lin; Yu-Jr Lin; Shuenn-Dhy Chang; Hui-Hsuan Wang
Journal:  Int Urogynecol J       Date:  2012-07-10       Impact factor: 2.894

2.  Urinary incontinence symptoms during and after pregnancy in continent and incontinent primiparas.

Authors:  Angela D Thomason; Janis M Miller; John Ol Delancey
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-20

3.  Peripartum urinary incontinence in a racially diverse obstetrical population.

Authors:  Fareesa Raza-Khan; Scott Graziano; Kim Kenton; Susan Shott; Linda Brubaker
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-01-25

4.  Influence of maternal weight on the new onset of stress urinary incontinence in pregnant women.

Authors:  Irene Diez-Itza; Larraitz Ibañez; Miren Arrue; Jone Paredes; Arantzazu Murgiondo; Cristina Sarasqueta
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-06-05

5.  A randomized controlled trial of antenatal pelvic floor exercises to prevent and treat urinary incontinence.

Authors:  Po-Chun Ko; Ching-Chung Liang; Shuenn-Dhy Chang; Jian-Tao Lee; An-Shine Chao; Po-Jen Cheng
Journal:  Int Urogynecol J       Date:  2010-08-25       Impact factor: 2.894

6.  Prevalence and correlates of stress urinary incontinence during pregnancy: a survey at UNICAMP Medical School, São Paulo, Brazil.

Authors:  K P Scarpa; V Herrmann; P C R Palma; C L Z Riccetto; S S Morais
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-07-15

7.  Urinary incontinence in nulliparous women before and during pregnancy: prevalence, incidence, and associated risk factors.

Authors:  Stephanie J Brown; Susan Donath; Christine MacArthur; Ellie A McDonald; Ann H Krastev
Journal:  Int Urogynecol J       Date:  2009-10-16       Impact factor: 2.894

Review 8.  Prevalence, incidence and bothersomeness of urinary incontinence in pregnancy: a systematic review and meta-analysis.

Authors:  Heidi F A Moossdorff-Steinhauser; Bary C M Berghmans; Marc E A Spaanderman; Esther M J Bols
Journal:  Int Urogynecol J       Date:  2021-01-13       Impact factor: 2.894

Review 9.  Stress urinary incontinence in pregnant women: a review of prevalence, pathophysiology, and treatment.

Authors:  Bussara Sangsawang; Nucharee Sangsawang
Journal:  Int Urogynecol J       Date:  2013-02-23       Impact factor: 2.894

10.  Antenatal pelvic floor muscle training and urinary incontinence: a randomized controlled 7-year follow-up study.

Authors:  Signe Nilssen Stafne; Rebecka Dalbye; Oda M Kristiansen; Yvonne E Hjelle; Kjell Åsmund Salvesen; Siv Mørkved; Hege Hølmo Johannessen
Journal:  Int Urogynecol J       Date:  2021-12-22       Impact factor: 1.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.